http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101869931-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2014-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101869931-B1 |
| titleOfInvention | Method of predicting sensitivity for molecular targeted anticancer drugs |
| abstract | The present invention relates to a method for predicting susceptibility to treatment with a vascular endothelial growth factor receptor (VEGFR) inhibitor. By predicting the effect of the inhibitor of VEGFR on hepatocellular carcinoma patients by the present invention, effective treatment and chemotherapy for hepatocellular carcinoma can be selected to improve the therapeutic effect and minimize side effects of liver cancer treatment do. |
| priorityDate | 2014-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 795.